Clinical Trial Update: The Role of Circulating Tumour DNA in Head and Neck Cancer

View source ↗

Summary

A clinical trial from the University of Edinburgh is investigating circulating tumour DNA as a biomarker in oropharyngeal squamous cell carcinoma, including HPV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: University of Edinburgh | Conditions: Oropharyngeal Squamous Cell Carcinoma, Human Papillomavirus (HPV) | Status: RECRUITING